• Publications
  • Influence
Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial.
A 20 micrograms/24 hours levonorgestrel-releasing intrauterine contraceptive device (LNG-IUD) has, in an open randomized multicenter study, been compared to the copper-releasing device Nova T duringExpand
  • 438
  • 30
Deliveries, mothers and newborn infants in Sweden, 1973–2000
Introduction.  The aim of this report is to present descriptive data from the Swedish Medical Birth Register (MBR) reflecting trends in obstetric and neonatal practices over three decades.
  • 125
  • 13
  • PDF
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Background. Recent studies have indicated that the risk of thromboembolic disease (VTE) in users of combined oral contraceptive pills (COCs) varies not only with estrogen dose, but also with theExpand
  • 142
  • 11
A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).
OBJECTIVE To review the safety and tolerability of the contraceptive patch (Ortho Evra/Evra) versus a standard oral contraceptive (Triphasil) and to present the pooled safety and tolerability of theExpand
  • 86
  • 9
Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use.
BACKGROUND This report comprises women from one center, who all participated in a larger European multi-center study, which included 2758 healthy women, of whom 1821 were randomly allocated to theExpand
  • 127
  • 7
Reasons for pregnancy termination, contraceptive habits and contraceptive failure among Swedish women requesting an early pregnancy termination
Background. More than 30 000 legal abortions are performed every year in Sweden despite sexual education in schools, widespread youth‐clinics and family planning services that are free of charge. TheExpand
  • 130
  • 6
Off‐Label Drug Use in Pediatric Patients
INTRODUCTION Until recently, it was considered unethical or impossible to perform clinical trials of new medicines in children. As a consequence, many medicines used for treating children areExpand
  • 165
  • 5
  • PDF
Ovarian function during use of a levonorgestrel-releasing IUD.
Ovarian function was studied for two complete menstrual cycles in 9 regularly menstruating women and for 8 weeks in three amenorrhoeic women who had used levonorgestrel-releasing IUDs (LNG-IUD) forExpand
  • 121
  • 3
Effects of Oral Contraceptives on Breast Epithelial Proliferation
The association between oral contraceptive (OC) use and breast cancer is not fully understood. Estrogen is a known mitogen to breast epithelial cells, but there is still a controversy about theExpand
  • 80
  • 3
  • PDF
Paediatric drug use with focus on off-label prescriptions at Swedish hospitals – a nationwide study
Aim:  To perform a nationwide investigation of paediatric drug use at Swedish hospitals, including an analysis of off‐label drug use.
  • 75
  • 3